Wall Street brokerages predict that Constellium NV (NYSE:CSTM) will announce $1.50 billion in sales for the current quarter, Zacks reports. Four analysts have made estimates for Constellium’s earnings, with the lowest sales estimate coming in at $1.42 billion and the highest estimate coming in at $1.56 billion. Constellium posted sales of $1.60 billion during the same quarter last year, which suggests a negative year over year growth rate of 6.3%. The business is expected to announce its next earnings results on Thursday, February 20th.
According to Zacks, analysts expect that Constellium will report full-year sales of $6.54 billion for the current fiscal year, with estimates ranging from $6.46 billion to $6.60 billion. For the next fiscal year, analysts anticipate that the business will report sales of $6.44 billion, with estimates ranging from $5.61 billion to $7.01 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that cover Constellium.
Constellium (NYSE:CSTM) last announced its earnings results on Wednesday, October 23rd. The industrial products company reported $0.01 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.28 by ($0.27). Constellium had a negative net margin of 0.28% and a negative return on equity of 12.92%. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.45 billion. During the same period in the previous year, the company earned $1.54 earnings per share. The business’s revenue for the quarter was up 2.3% on a year-over-year basis.
Several equities research analysts recently issued reports on CSTM shares. Credit Suisse Group upped their price target on Constellium from $20.00 to $23.00 and gave the company an “outperform” rating in a research report on Tuesday, October 15th. ValuEngine lowered Constellium from a “buy” rating to a “hold” rating in a research report on Saturday, October 5th.
A number of institutional investors and hedge funds have recently modified their holdings of the stock. FMR LLC grew its stake in shares of Constellium by 24.9% in the first quarter. FMR LLC now owns 4,166,800 shares of the industrial products company’s stock worth $33,251,000 after purchasing an additional 829,800 shares in the last quarter. Segantii Capital Management Ltd bought a new position in shares of Constellium in the second quarter worth $502,000. Boussard & Gavaudan Investment Management LLP grew its stake in shares of Constellium by 6.2% in the second quarter. Boussard & Gavaudan Investment Management LLP now owns 2,800,293 shares of the industrial products company’s stock worth $28,577,000 after purchasing an additional 163,629 shares in the last quarter. Quantitative Systematic Strategies LLC grew its stake in shares of Constellium by 50.7% in the second quarter. Quantitative Systematic Strategies LLC now owns 42,934 shares of the industrial products company’s stock worth $431,000 after purchasing an additional 14,441 shares in the last quarter. Finally, Signaturefd LLC bought a new position in shares of Constellium in the second quarter worth $40,000. Hedge funds and other institutional investors own 66.67% of the company’s stock.
Shares of CSTM traded up $0.16 during trading on Thursday, reaching $14.35. The company’s stock had a trading volume of 784,743 shares, compared to its average volume of 1,082,745. The company has a fifty day moving average of $13.40 and a two-hundred day moving average of $11.23. Constellium has a twelve month low of $6.26 and a twelve month high of $14.79. The company has a market cap of $1.95 billion, a price-to-earnings ratio of 20.21 and a beta of 1.75.
Constellium N.V. engages in the design, manufacture, and sale of specialty rolled and extruded aluminum products for the aerospace, packaging, and automotive end-markets. The company operates in three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
Further Reading: What does an outperform rating mean?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.